Skip to content
  • Home
  • News of the month
  • News
    • Biotech & biomedicine
    • Environmental Solutions
    • International
  • Downloads
    • Blick nach Asien
  • Archive
  • Home
  • News of the month
  • News
    • Biotech & biomedicine
    • Environmental Solutions
    • International
  • Downloads
    • Blick nach Asien
  • Archive

Japannewsticker_mobile

Japan Approves World’s First Allogeneic iPS Cell-Derived Therapy for Parkinson’s Disease

Categories: Biotech & biomedicine,News

Tohoku genome data reveal variants relevant to personalised chemotherapy

Categories: Biotech & biomedicine,News

A Japanese consortium develops high-throughput integrated droplet screening system to discover hitherto uncultivatable microbes and enzymes

Categories: Biotech & biomedicine,News

Japan Launches AI Platform to Accelerate Chemical Synthesis Development

Categories: News

Japan will establish a dedicated beamline at SPring-8-II to analyze fuel cell and water electrolysis materials “in-situ” while operating

Categories: Environmental solutions,News

Japan’s first successful prototype production of reduced iron using green hydrogen

Categories: Environmental solutions,News

CO2-Sequestering through using artificial limestone in construction projects: Sumitomo Osaka Cement and Taisei Corp.

Categories: Environmental solutions,News

Osaka Institute of Technology opens Bio-Manufacturing Center

Categories: Biotech & biomedicine,News

NTT and TBS television will create AI theme park for children edutainment

Categories: News

A solid gel pad containing tamarind seed gum for human ultrasound diagnostic

Categories: Biotech & biomedicine,News

ein Service von Bio4Business

Linkedin
  • Privacy
  • Imprint
  • Cookie Policy (EU)

© COPYRIGHT 2022 WINDOW TO Japan / bio4business

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}